Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.79 CNY
2.39 B CNY
41.13 B CNY
1.22 B
About SHANGHAI FOSUN PHARMACEUTICAL (GROUP)
Sector
CEO
De Yong Wen
Headquarters
Shanghai
Website
Founded
1994
ISIN
CNE000000X38
FIGI
BBG000C4SRF1
Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600196 is 27.29 CNY — it has increased by 1.56% in the past 24 hours. Watch SHANGHAI FOSUN PHARMACEUTICAL (GROUP) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange SHANGHAI FOSUN PHARMACEUTICAL (GROUP) stocks are traded under the ticker 600196.
600196 stock has fallen by −1.87% compared to the previous week, the month change is a 7.87% rise, over the last year SHANGHAI FOSUN PHARMACEUTICAL (GROUP) has showed a −3.87% decrease.
We've gathered analysts' opinions on SHANGHAI FOSUN PHARMACEUTICAL (GROUP) future price: according to them, 600196 price has a max estimate of 31.00 CNY and a min estimate of 23.05 CNY. Watch 600196 chart and read a more detailed SHANGHAI FOSUN PHARMACEUTICAL (GROUP) stock forecast: see what analysts think of SHANGHAI FOSUN PHARMACEUTICAL (GROUP) and suggest that you do with its stocks.
600196 reached its all-time high on Aug 5, 2021 with the price of 91.69 CNY, and its all-time low was 2.13 CNY and was reached on Apr 26, 2006. View more price dynamics on 600196 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600196 stock is 1.29% volatile and has beta coefficient of 1.08. Track SHANGHAI FOSUN PHARMACEUTICAL (GROUP) stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI FOSUN PHARMACEUTICAL (GROUP) there?
Today SHANGHAI FOSUN PHARMACEUTICAL (GROUP) has the market capitalization of 71.50 B, it has increased by 0.97% over the last week.
Yes, you can track SHANGHAI FOSUN PHARMACEUTICAL (GROUP) financials in yearly and quarterly reports right on TradingView.
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) is going to release the next earnings report on Mar 31, 2025. Keep track of upcoming events with our Earnings Calendar.
600196 earnings for the last quarter are 0.29 CNY per share, whereas the estimation was 0.29 CNY resulting in a −1.69% surprise. The estimated earnings for the next quarter are 0.28 CNY per share. See more details about SHANGHAI FOSUN PHARMACEUTICAL (GROUP) earnings.
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) revenue for the last quarter amounts to 10.45 B CNY, despite the estimated figure of 10.34 B CNY. In the next quarter, revenue is expected to reach 10.84 B CNY.
600196 net income for the last quarter is 785.84 M CNY, while the quarter before that showed 615.06 M CNY of net income which accounts for 27.77% change. Track more SHANGHAI FOSUN PHARMACEUTICAL (GROUP) financial stats to get the full picture.
Yes, 600196 dividends are paid annually. The last dividend per share was 0.27 CNY. As of today, Dividend Yield (TTM)% is 1.01%. Tracking SHANGHAI FOSUN PHARMACEUTICAL (GROUP) dividends might help you take more informed decisions.
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) dividend yield was 1.08% in 2023, and payout ratio reached 30.39%. The year before the numbers were 1.12% and 27.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 40.37 K employees. See our rating of the largest employees — is SHANGHAI FOSUN PHARMACEUTICAL (GROUP) on this list?
Like other stocks, 600196 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI FOSUN PHARMACEUTICAL (GROUP) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI FOSUN PHARMACEUTICAL (GROUP) technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI FOSUN PHARMACEUTICAL (GROUP) stock shows the neutral signal. See more of SHANGHAI FOSUN PHARMACEUTICAL (GROUP) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.